...
机译:白细胞介素-8作为对头部和颈部鳞状细胞癌的临床前模型对Bevacizumab的反应的调节剂
Department of Pharmacology and Chemical Biology University of Pittsburgh School of Medicine;
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston TX;
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston TX;
Department of Otolaryngology University of Pittsburgh School of Medicine 200 Lothrop Street;
Department of Otolaryngology University of Pittsburgh School of Medicine 200 Lothrop Street;
Department of Otolaryngology University of Pittsburgh School of Medicine 200 Lothrop Street;
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston TX;
Department of Pharmacology and Chemical Biology University of Pittsburgh School of Medicine;
Angiogenesis; Bevacizumab; Biomarker; HNSCC; IL-8 Resistance;
机译:白细胞介素8在头颈部鳞状细胞癌的临床前模型中对贝伐单抗的应答调节剂
机译:西妥昔单抗和贝伐单抗:头颈部复发或转移性鳞状细胞癌的临床前数据和II期试验
机译:头颈鳞状细胞癌的临床前模型,对癌症生物学的基本理解及其翻译成高效疗法
机译:利用蛋白质组学数据预测头颈部鳞状细胞癌分期的模型
机译:PD-L1特异性辅助性T细胞表现出有效的抗肿瘤反应:针对头颈部鳞状细胞癌中PD-L1的癌症免疫疗法的新策略。
机译:西妥昔单抗和贝伐单抗:头颈部复发或转移性鳞状细胞癌的临床前数据和II期试验
机译:头颈部鳞状细胞癌细胞系和人类肿瘤的基因组分析:临床前模型选择的合理方法